Overview

Prevention of Coronary Aneurysms in Kawasaki Syndrome

Status:
Completed
Trial end date:
1989-11-01
Target enrollment:
Participant gender:
Summary
To test the efficacy of intravenous gamma globulin (IVGG) in preventing coronary artery aneurysms in children with Kawasaki Syndrome.
Phase:
Phase 2
Details
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Antibodies
Aspirin
gamma-Globulins
Immunoglobulins
Immunoglobulins, Intravenous
Rho(D) Immune Globulin